ArticleInternational journal of molecular sciences2023

Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes.

Ingrid Reppo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.